Lasa Supergenerics Limited (LASA) Share Price & AI Investment Analysis

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports i. Track Lasa Supergenerics Limited's live NSE:LASA share price ₹5.89 (-5.00%), market cap ₹₹30Cr. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for LASA — real-time NSE India stock intelligence.